These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

928 related items for PubMed ID: 19387578

  • 21. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca.
    Civantos B, Aleixandre A.
    Eur J Pharmacol; 2004 Apr 05; 489(1-2):101-10. PubMed ID: 15063161
    [Abstract] [Full Text] [Related]

  • 22. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep 05; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 23. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ.
    Am J Hypertens; 2005 Nov 05; 18(11):1496-502. PubMed ID: 16280288
    [Abstract] [Full Text] [Related]

  • 24. Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Teräväinen TL, Malmberg L, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1997 Jun 05; 121(3):503-10. PubMed ID: 9179393
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive therapy with CCB/ARB combination in older individuals: focus on amlodipine/valsartan combination.
    Kostis JB.
    Am J Ther; 2010 Jun 05; 17(2):188-96. PubMed ID: 19433970
    [Abstract] [Full Text] [Related]

  • 26. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE.
    J Hum Hypertens; 2006 Nov 05; 20(11):860-6. PubMed ID: 16988754
    [Abstract] [Full Text] [Related]

  • 27. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 05; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 28. Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously hypertensive rats.
    Ling G, Liu AJ, Shen FM, Cai GJ, Liu JG, Su DF.
    Acta Pharmacol Sin; 2007 Nov 05; 28(11):1755-60. PubMed ID: 17959026
    [Abstract] [Full Text] [Related]

  • 29. [Contrast of losartan, fosinopril and amlodipine on cardiomyocyte apoptosis and left ventricular remolding in hypertensive rats].
    Yu GL, Liang XQ, Zheng JQ.
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct 28; 26(5):405-8. PubMed ID: 12536482
    [Abstract] [Full Text] [Related]

  • 30. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun 28; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 31. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G, Liang X, Xie X, Yang T, Sun M, Zhao S.
    Chin Med J (Engl); 2002 Sep 28; 115(9):1287-91. PubMed ID: 12411096
    [Abstract] [Full Text] [Related]

  • 32. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
    Kim S, Zhan Y, Izumi Y, Iwao H.
    Hypertension; 2000 Mar 28; 35(3):769-74. PubMed ID: 10720593
    [Abstract] [Full Text] [Related]

  • 33. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S.
    J Pharmacol Exp Ther; 2011 Nov 28; 339(2):358-66. PubMed ID: 21807884
    [Abstract] [Full Text] [Related]

  • 34. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.
    Sevilla MA, Voces F, Carrón R, Guerrero EI, Ardanaz N, San Román L, Arévalo MA, Montero MJ.
    Life Sci; 2004 Jul 02; 75(7):881-91. PubMed ID: 15183079
    [Abstract] [Full Text] [Related]

  • 35. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
    Yamada Y, Tsuboi K, Hattori T, Murase T, Ohtake M, Furukawa M, Ueyama J, Nishiyama A, Murohara T, Nagata K.
    Hypertens Res; 2011 Jul 02; 34(7):809-16. PubMed ID: 21471973
    [Abstract] [Full Text] [Related]

  • 36. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M, Davis BJ, Allen TJ, Burrell LM, Cooper ME, Cao Z.
    Clin Sci (Lond); 2003 Apr 02; 104(4):341-7. PubMed ID: 12653675
    [Abstract] [Full Text] [Related]

  • 37. Effects of angiotensin II type-1 receptor blocker losartan on age-related cardiovascular risk in spontaneously hypertensive rats.
    Mihailović-Stanojević N, Miloradović Z, Grujić-Milanović J, Ivanov M, Jovović D.
    Gen Physiol Biophys; 2009 Apr 02; 28 Spec No():112-8. PubMed ID: 19893088
    [Abstract] [Full Text] [Related]

  • 38. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ.
    Int Angiol; 2010 Jun 02; 29(3):266-72. PubMed ID: 20502415
    [Abstract] [Full Text] [Related]

  • 39. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A, Leibowitz A, Yamamoto N, Rautureau Y, Paradis P, Schiffrin EL.
    Hypertension; 2012 Feb 02; 59(2):291-9. PubMed ID: 22184324
    [Abstract] [Full Text] [Related]

  • 40. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
    Baumann M, Hermans JJ, Janssen BJ, Peutz-Kootstra C, Witzke O, Heemann U, Smits JF, Boudier HA.
    J Hypertens; 2007 Dec 02; 25(12):2504-11. PubMed ID: 17984673
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 47.